Drug Type ASO |
Synonyms- |
Target |
Mechanism CD39 inhibitors(Ectonucleoside triphosphate diphosphohydrolase 1 inhibitors), PD-1 agonists(Programmed cell death protein 1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CH | 12 Mar 2019 | |
Neoplasms | Preclinical | DE | 12 Mar 2019 |